Dr. Michael Cummings discusses various topics including the effects of Valproic Acid in men during pregnancy, differences between lithium and Depakote as mood stabilizers, sustainability of Electroconvulsive Therapy for chronic catatonia, early signs of psychopathy in children, restless leg syndrome, timing for checking lithium levels, treatment of dementia patients, and innovative treatments in psychiatry. He also shares his personal journey from losing sight in the Navy to becoming a psychiatrist.
Dr. Cummings prefers haloperidol as an antipsychotic due to versatility and mood stabilization.
Research suggests valproic acid poses reproductive risks, prompting restrictions in the EU and UK.
Deep dives
Psychiatry Insights - Choosing Psychiatric Medications for Long-Term Maintenance
When faced with the challenge of treating people on a desert island in the foreseeable future with only three psychiatric medications, Dr. Michael Cummings deliberates on his choices. He opts for haloperidol as an antipsychotic due to its versatility and mood stabilization. Next, he considers lithium or valproic acid as mood stabilizers, highlighting concerns about valproic acid's reproductive risks. For antidepressant purposes, he leans towards sertraline, citing its broad applicability and tolerability for depression and anxiety disorders.
Valproic Acid Concerns - Regulatory Measures and Impact on Neurobehavioral Disorders
Dr. Cummings discusses the research surrounding valproic acid's impact on neurobehavioral disorders in children born to men taking the medication. Studies suggest an increased risk of neurobehavioral issues, emphasizing the need for caution. While the FDA is yet to act on this data, the European Union and UK have already implemented restrictions on valproic acid usage due to these concerns.
Treatment Challenges and Considerations in Bipolar Disorder
In a hypothetical scenario discussing the choice between lithium and Depakote for treating bipolar disorder, Dr. Cummings favors lithium for its broader efficacy and risk reduction relating to suicide and violence. He points out the potential limitations of lithium, considering its narrow therapeutic index and renal function implications. Additionally, he addresses criticisms on lithium's supposed limitations in reducing suicidal risk.
Navigating Medication Tapering and Management in Clinical Practice
Dr. Michael Cummings provides advice on tapering benzodiazepines, emphasizing the importance of a slow and patient-centered approach, especially for long-term users. He recommends gradual reductions, highlighting the complexities of tapering strategies and the necessity of individualized plans based on patients' needs and responses.
In this episode, we welcome back Dr. Michael Cummings to answer questions sent in by podcast listeners. Topics include Valproic Acid, Lithium, Treating Veterans, Restless Leg Syndrome, and much more.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode